$XTALPI(02228.HK) What I've always been curious about is, where has the downward momentum in the pharmaceutical sector come from in the past six months or so? Of course, I think insufficient liquidity would be the primary reason. The liquidity in Hong Kong stocks, especially in the pharmaceutical sector, is really too poor. Secondly, it comes from institutions, particularly the two previous share placements and possible structural short-selling by related institutions, which could also be important factors. Of course, this is just my speculation. There's no specific data to support it. This has led to the oversold condition of this stock reaching an outrageous level. But against the backdrop of insufficient liquidity, it's not surprising that it continues to fall. It's just so bitter.